Description
What is the use of sacituzumab govitecan-hziy for injection?
TRODELVY (sacituzumab govitecan-hziy) medication is used to treat adults with a type of breast cancer known as triple-negative breast cancer.
Sacituzumab govitecan, sold under the brand name Trodelvy, is a Trop-2-directed antibody and topoisomerase inhibitor drug conjugate used for the treatment of metastatic triple-negative breast cancer and metastatic urothelial cancer. The U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) consider it to be a first-in-class medication.
FDA grants accelerated approval to sacituzumab govitecan-hziy for metastatic triple negative breast cancer. On April 22, 2020, the Food and Drug Administration granted accelerated approval to sacituzumab govitecan-hziy (TRODELVY, Immunomedics, Inc.) for adult patients with metastatic triple-negative breast cancer who received at least two prior therapies for metastatic disease.
Has TRODELVY (sacituzumab govitecan-hziy) been launched in India?
No, TRODELVY (sacituzumab govitecan-hziy) is not officially launched or commercially marketed for regular sale in India yet. To get access, give a request to Lucknow Speciality Pharma team.
Patient Access Facilitation for TRODELVY (sacituzumab govitecan-hziy)
TRODELVY (sacituzumab govitecan-hziy) for Injection is an unregistered/restricted drug in India. The Lucknow Speciality Pharma acts purely as a logistics and documentation facilitator to assist patients and hospitals in accessing TRODELVY (sacituzumab govitecan-hziy) strictly for personal medical use under the Named Patient Program (NPP), in full compliance with the Drugs and Cosmetics Rules and guidelines set by the Central Drugs Standard Control Organisation (CDSCO).
To give request – contact sourcing facilitation team
Contact Name: Jitender Mishra
Company Name: Lucknow Speciality pharma
Address: 2nd Floor, 207-A, Felix Square, Golf City, Gomti Nagar, Lucknow, Uttar Pradesh 226030
NEWS / UPDATES
- For TRODELVY (sacituzumab govitecan-hziy)Indications And Usage, Dosage And Administration, Dosage Forms And Strengths and Drug Interactions For More Details
- Gilead Announces Clinical Trial Collaboration With Merck to Evaluate Trodelvy® (sacituzumab govitecan-hziy) in Combination With KEYTRUDA® (pembrolizumab) in Patients With First-Line Metastatic Triple-Negative Breast Cancer For More Details
- FDA grants accelerated approval to sacituzumab govitecan-hziy for metastatic triple negative breast cancer For More Details
- Gilead and MSD collab on Trodelvy/Keytruda breast cancer trial For More Details
Disclaimer:
TRODELVY (sacituzumab govitecan-hziy) for Injection is not commercially marketed or locally stocked for open retail distribution in India. Access is facilitated exclusively under the Named Patient Program (NPP) framework governed by the Central Drugs Standard Control Organisation (CDSCO) and Rule 36 of the Drugs & Cosmetics Rules. All imports require a valid prescription from a Registered Medical Practitioner, mandatory regulatory approvals, and are strictly for individual personal use. The Lucknow Speciality Pharma functions solely as a regulatory documentation and logistics facilitation service provider.
FAQs
How to Access TRODELVY in India?
Under the Named Patient Program (NPP), patients in India can legally import non-registered, life-saving medications like TRODELVY (sacituzumab govitecan-hziy) for injection for personal medical use. This process is compliant with Rule 36 of the Drugs & Cosmetics Rules, 1945, and subject to approval from the Central Drugs Standard Control Organisation (CDSCO).
What is the role of Lucknow Speciality Pharma?
On request,
Lucknow Speciality Pharma assists patients, treating specialists, and hospitals by facilitating the legal sourcing and import process through authorized global pharmaceutical networks.
We assist with:
- Processing regulatory documentation and CDSCO import permit filings (Form 12A/12B).
- Coordinating customs clearance and end-to-end import formalities.
- Managing GDP-compliant, temperature-controlled cold-chain logistics for direct delivery to hospitals or individual patients.
How much do TRODELVY (sacituzumab govitecan-hziy) for injection cost in Lucknow, India?
The cost of TRODELVY is variable and may depend on factors such as the source of procurement, applicable duties and taxes, and import logistics. Accordingly, it is advisable to consult a specialized facilitator to obtain accurate and up-to-date pricing and availability details. To procure this medication legally, you can call at
9336559090 or WhatsApp at
9336559090 or email us at
info@lucknowpharma.com
Where does The Lucknow Speciality Pharma supply medicines and medical products?
The
Lucknow Speciality Pharma supports healthcare facilities, medical practitioners, and individual patients across 10 regional territories—including Uttar Pradesh, Uttarakhand, Haryana, Delhi (NCR), Rajasthan, Madhya Pradesh, Chhattisgarh, Bihar, Jharkhand, and Nepal.
Key Metropolitan & Regional Delivery Hubs:
- Delhi (NCR): Delhi, Gurugram, Noida, Greater Noida, Ghaziabad.
- Uttar Pradesh: Lucknow, Kanpur, Prayagraj, Varanasi, Agra, Meerut, Bareilly, Gorakhpur, Aligarh, Moradabad, Jhansi, Mathura–Vrindavan, Ayodhya, and surrounding districts.
- Eastern & Central India: Patna, Gaya, Bhagalpur, Muzaffarpur, Darbhanga (Bihar); Ranchi (Jharkhand); Bhopal, Indore (Madhya Pradesh); Raipur (Chhattisgarh); Jaipur (Rajasthan); Dehradun (Uttarakhand).
- Expanded Regional Coverage: Guwahati (Assam), Agartala (Tripura), Imphal (Manipur), Kolkata, Siliguri, Asansol (West Bengal), and Nepal.